106 related articles for article (PubMed ID: 24803071)
1. PEGylation of lysine residues improves the proteolytic stability of fibronectin while retaining biological activity.
Zhang C; Desai R; Perez-Luna V; Karuri N
Biotechnol J; 2014 Aug; 9(8):1033-43. PubMed ID: 24803071
[TBL] [Abstract][Full Text] [Related]
2. Proteolytically stabilizing fibronectin without compromising cell and gelatin binding activity.
Zhang C; Ramanathan A; Karuri NW
Biotechnol Prog; 2015; 31(1):277-88. PubMed ID: 25394993
[TBL] [Abstract][Full Text] [Related]
3. PEGylated human plasma fibronectin is proteolytically stable, supports cell adhesion, cell migration, focal adhesion assembly, and fibronectin fibrillogenesis.
Zhang C; Hekmatfar S; Ramanathan A; Karuri NW
Biotechnol Prog; 2013; 29(2):493-504. PubMed ID: 23319204
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis of decellularized extracellular matrices results in loss of fibronectin and cell binding activity.
Ramanathan A; Karuri N
Biochem Biophys Res Commun; 2015 Apr; 459(2):246-251. PubMed ID: 25724944
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin-based masking molecule blocks platelet adhesion.
Geho DH; Smith WI; Liotta LA; Roberts DD
Bioconjug Chem; 2003; 14(4):703-6. PubMed ID: 12862420
[TBL] [Abstract][Full Text] [Related]
6. Cell motility on polyethylene glycol block copolymers correlates to fibronectin surface adsorption.
Röttgermann PJ; Hertrich S; Berts I; Albert M; Segerer FJ; Moulin JF; Nickel B; Rädler JO
Macromol Biosci; 2014 Dec; 14(12):1755-63. PubMed ID: 25204968
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a large soluble form of fibronectin that stimulates adhesion, spreading, and alignment of mouse erythroleukemia cells.
Scher BM; Mistry SJ; Haque NS; Scher W
Exp Cell Res; 2010 Sep; 316(15):2402-13. PubMed ID: 20547151
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of polyethylene glycol hydrogels derivatized with the RGD peptide and the cell-binding domain of fibronectin.
Zhang C; Hekmatfer S; Karuri NW
J Biomed Mater Res A; 2014 Jan; 102(1):170-9. PubMed ID: 23613303
[TBL] [Abstract][Full Text] [Related]
9. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
[TBL] [Abstract][Full Text] [Related]
10. A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cells.
Kato K; Mohri H; Tamura T; Okubo T
Biochem Biophys Res Commun; 1997 Oct; 239(1):205-11. PubMed ID: 9345296
[TBL] [Abstract][Full Text] [Related]
11. PEGylation of lysine residues reduces the pro-migratory activity of IGF-I.
Sivaramakrishnan M; Kashyap AS; Amrein B; Saenger S; Meier S; Staudenmaier C; Upton Z; Metzger F
Biochim Biophys Acta; 2013 Oct; 1830(10):4734-42. PubMed ID: 23800578
[TBL] [Abstract][Full Text] [Related]
12. Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility.
Mooradian DL; McCarthy JB; Skubitz AP; Cameron JD; Furcht LT
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):153-64. PubMed ID: 8425821
[TBL] [Abstract][Full Text] [Related]
13. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
[TBL] [Abstract][Full Text] [Related]
14. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype.
Giuffrida A; Scarpa S; Birarelli P; Modesti A
Int J Oncol; 2004 Sep; 25(3):745-50. PubMed ID: 15289878
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin.
Ugarova TP; Ljubimov AV; Deng L; Plow EF
Biochemistry; 1996 Aug; 35(33):10913-21. PubMed ID: 8718884
[TBL] [Abstract][Full Text] [Related]
16. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.
Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN
Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592
[TBL] [Abstract][Full Text] [Related]
17. Multiscale relationships between fibronectin structure and functional properties.
Bradshaw MJ; Smith ML
Acta Biomater; 2014 Apr; 10(4):1524-31. PubMed ID: 23978411
[TBL] [Abstract][Full Text] [Related]
18. PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokinetics.
Yu W; Yu C; Wu L; Fang T; Qiu R; Zhang J; Yu T; Fu L; Chen W; Hu T
Antiviral Res; 2014 Aug; 108():142-7. PubMed ID: 24936771
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein.
Alon R; Cahalon L; Hershkoviz R; Elbaz D; Reizis B; Wallach D; Akiyama SK; Yamada KM; Lider O
J Immunol; 1994 Feb; 152(3):1304-13. PubMed ID: 7905501
[TBL] [Abstract][Full Text] [Related]
20. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
